| INTRODUC TI ON
Gastroenterology training has moved successfully to competencybased education in the US, where an organized framework of competencies is utilized to ensure that the trainee has adequate knowledge, skills, attitudes and values to function as a specialist. 1 The benefit of competency-based training includes the facts that education is streamlined using a structured curriculum and that training outcomes are aligned with the trainee's career objectives and societal needs of the field. 1 Gastroenterology consists of several subspecialty fields, including luminal gastroenterology, inflammatory bowel disease, hepatology, biliary disease and pancreatology, and opportunities for subspecialization exist within each of these areas. Trainees recognize the challenges of a general gastroenterological career encompassing all these subspecialty fields, which can include clinical practice, clinical investigation, translational and basic research, and combinations thereof. Within this complex conundrum, gravitation toward a niche area of interest and expertise has become the norm rather than the exception for gastroenterology trainees and practitioners in recent years. One such niche area is neurogastroenterology and motility (NGM), which encompasses the study of the brain, the gut, and how they interact; Competency-based education requires a description of the scope of training, which has not been systematically evaluated within NGM societies for NGM disorders, 5 despite the fact that NGM is an important component of the gastroenterology curriculum, 6 and entrustable professional activities expected of trained gastroenterologists includes the understanding and management of NGM disorders. 7 In the context of tailoring training components and outcome to trainee and societal needs, the
American Neurogastroenterology and Motility Society (ANMS) initiated the idea of defining expectations for NGM training in
North America by creating a task force. The project extended to a collaborative joint task force with the European Society of Neurogastroenterology and Motility (ESNM). Members of both the ANMS and ESNM joined forces and deliberated over the training components, in order to establish knowledge, skills, attitudes, and values expected of NGM providers of varying expertise. The fact that this report is not meant to be prescriptive may be a limitation of the process, as the task forces did not try to establish the precise didactic content, rotation structure, and procedure interpretation expectations of NGM training. On the contrary, the task forces jointly agreed that this report needed to be inclusive and broad based, establishing the basis for streamlining NGM training expectations in both North America and Europe, and for potential quality control over procedures and interventions expected of NGM providers. In time, a similar curriculum-based approach could potentially be implemented in other regions of the world, thereby enhancing learning, and striving toward the shared goal of uniformity in NGM training.
identified within NGM, consisting of functional gastrointestinal disorders, visceral hypersensitivity and pain pathways, motor disorders within anatomic areas (esophagus, stomach, small bowel and colon, anorectum), mucosal disorders (gastroesophageal reflux disease, other mucosal disorders), consequences of systemic disease, consequences of therapy (surgery, endoscopic intervention, medications, other therapy), and transition of pediatric patients into adult practice. A 3-tiered training curriculum covering these domains is proposed here and endorsed by all NGM societies. Tier 1 NGM knowledge and training is expected of all gastroenterology trainees and practicing gastroenterologists. Tier 2 knowledge and training is appropriate for trainees who anticipate NGM disorder management and NGM function test interpretation being an important part of their careers, which may require competency assessment and credentialing of test interpretation skills. Tier 3 knowledge and training is undertaken by trainees interested in a dedicated NGM career and may be restricted to specific domains within the broad NGM field. The joint ANMS and ESNM task force anticipates that the NGM curriculum will streamline NGM training in North America and Europe and will lead to better identification of centers of excellence where Tier 2 and Tier 3 training can be accomplished.
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| A TIERED APPROACH TO NG M TR AINING
As the learning and practice environment has become nuanced and goal directed toward specific GI careers, it is important for educators and educational programs to develop strategies to provide relevant training to the trainee with specific career interests. 8 Consequently, both the educational program and the trainee need to recognize elements of training that are essential to the trainee's career and take ownership of the timing and content of learning. 8 A tiered approach to training serves this purpose, where the trainee is provided training and knowledge that directly relates to what the trainee needs from the training program.
Using tiers of training to allow trainees to gravitate toward their subspecialty niche of interest is not a new concept. 9 The
Gastroenterology Core Curriculum describes an 18-month core training (level 1 training) encompassing all aspects of gastroenterology, accounting for half of a 3-year fellowship in gastroenterology in the US. 6 The remainder of the fellowship training provides time for additional training directed toward the trainee's specific area of interest, either clinical, investigative, or laboratory-based, with the expectation of additional skills that will align with the trainee's F I G U R E 1 Hierarchical tiered system of neurogastroenterology and motility (NGM) training. Broad-based Tier 1 knowledge is expected of all general gastroenterology trainees and practitioners. Tier 2 knowledge and skills are acquired from association with an NGM center of excellence, following adequate demonstration of Tier 1 knowledge. Clinical knowledge and procedural competency can be assessed and credentialed by NGM societies following Tier 2 training. Tier 3 training may be limited to specific domain(s) within NGM and requires additional training beyond general gastroenterology training at an NGM center of excellence. It is anticipated that Tier 2 and Tier 3 training, assessment of Tier 2 competency, and credentialing will be administered and reported by NGM societies
TA B L E 1 Tiers of neurogastroenterology and motility training

Description Expectations
Tier 1
The general gastroenterologist completing GI specialty training, without special interest in NGM.
• recognize functional and motor disorders that fall within the realm of NGM • order basic investigation and initiate management of these disorders • understand settings where advanced opinion and management are required from Tier 2 or Tier 3 experts
Tier 2
The gastroenterologist with interest and expertise in aspects of NGM, while maintaining a broader gastroenterology interest and practice.
• expectations as outlined for Tier 1 training • perform and interpret function tests pertaining to motor function following special training or apprenticeship within NGM • integrate a multidisciplinary approach to management of NGM disorders • refer complex patients to Tier 3 experts
Tier 3
The neurogastroenterologist and/or motility expert, with a career focus within NGM, and practice limited to NGM disorders
• expectations as outlined for Tiers 1 and 2 training • career interest may be clinical, translational, basic, or combinations thereof, and may either be limited to a particular subarea or anatomic extent within NGM or broad based covering all aspects of NGM • provide expert opinion and management NGM disorders • develop a local, regional, national or international reputation as an expert within aspects of NGM career goals (level 2 training). A similar concept is envisioned for NGM training, but with three tiers (Table 1) , covering three levels of expected expertise in NGM disorders. While the first two tiers can be accomplished within the constraints of a structured fellowship or postdoctoral training program, additional training and experience are typically needed to achieve expertise at the Tier 3 level (Figure 1 ).
While the typical duration of Tier 3 training is 1 year, there are variations, from 3 to 6 months' training in a motility center of excellence, to as long as 2-3 years of mentor-guided research experience in a laboratory serving specific domains within NGM.
Since NGM disorders are among the most frequent conditions encountered in gastroenterology practice, 10, 11 it is essential for all gastroenterologists to have a working knowledge of common NGM disorders. This represents Tier 1 NGM training, and components within this tier are expected to be included in the general gastroenterology fellowship training applicable to all fellows ( The components of each domain are described in Table 2 . The description of each domain and the expectations of practitioners achieving each Tier of training within that domain are first described.
| CLINI C AL K NOWLEDG E COMP ONENTS OF THE NG M CURRI CULUM
Following this, the granular components of each domain are further distilled down into the three tiers of training and knowledge.
The task forces were in agreement that NGM training needed to include knowledge and understanding of conditions that could mimic NGM disorders. In particular, mucosal disorders such as Visceral pain can be part of several functional and organic GI disorders (eg, diseases of the pancreas) but can also manifest as its own entity. Furthermore, visceral pain can overlap with somatic disorders and can be a consequence of intervention (eg, surgery and endoluminal procedures), part of systemic diseases or result from medication use. In contrast to pain in somatic disorders, visceral pain is characterized by diffuse pain, major autonomic symptoms, referred pain to other visceral and somatic structures, and changing pain characteristics over time. This complicates diagnostics, and additionally, most analgesics have major side effects on the GI tract that need attention by the clinician. The Tier 1 consultant should recognize basic concepts regarding visceral pain, and its recognition in the clinical presentation of symptomatic patients. Furthermore, the consultant should understand the use of analgesics, neuromodulators, and other approaches to managing visceral pain. The Tier 2 consultant should develop expert understanding of pain pathways, become familiar with the concepts of visceral sensation and brain-gut axis, recognize evaluation of rare pain syndromes, and gain experience in the use of pharmacologic and non-pharmacologic approaches for control and management of visceral pain. The Tier 3 consultant should develop in-depth knowledge regarding pain mechanisms, including hollow gut and solid organ pain (such as pain from pancreatic diseases), and provide expert opinion regarding routine, novel, and anecdotal approaches to management of visceral pain.
(Continues) Gastro-esophageal reflux disease (GERD) is one of the most frequent reasons for GI consultation, with both typical (heartburn, regurgitation) and atypical (chest pain, dysphagia, chronic cough, laryngeal symptoms) manifestations and complications (Barrett's esophagus, peptic stricture, esophageal adenocarcinoma). The Tier 1 consultant should recognize the presentation and complications of GERD, utilization of testing in diagnosis and surveillance for complications, and basic management. The Tier 2 consultant should understand the mechanisms of GERD; the indications, basic interpretation, limitations, and complications of diagnostic testing; and provide detailed management of GERD. The Tier 3 consultant should have an in-depth understanding of GERD pathophysiology, performance and expert interpretation of esophageal testing, GERD therapeutics, GERD complications and their management, and provide expert opinion on all aspects of diagnosis and management. 
Tier 2 • Describe the detailed presentation, diagnosis, investigation, phenotyping (erosive esophagitis or non-erosive reflux disease), and management of GERD and its complications • Understand specific pathophysiologic abnormalities relevant to GERD diagnosis and management: TLESRs, acid pocket, contraction reserve, HRM metrics in GERD • Acquire knowledge to interpret ambulatory reflux monitoring studies, especially pH monitoring, and esophageal manometry studies performed in the context of GERD • Recognize esophageal disorders that mimic GERD, including disorders of belching and regurgitation • Recognize situations where surgical intervention is indicated for GERD management and identify appropriate indications • Identify complications and risk factors for poor outcome in the management of GERD Tier 3
• Expert interpretation of esophageal testing in the context of GERD diagnosis and management recommendations, including interpretation of pH-impedance monitoring • Recognize indications and appropriate candidates for endoscopic GERD therapies.
• Provide diagnosis and management of complications of GERD management, including GERD recurrence after antireflux surgery • Recognize and provide detailed management of conditions mimicking GERD, including functional syndromes (functional heartburn, reflux hypersensitivity, rumination, and supragastric belching) • Integrate GERD management in patients with comorbidities
Esophageal motor disorders Description
Oropharyngeal and esophageal motor disorders can present with dysphagia, heartburn, regurgitation, aspiration, chest pain, or weight loss. The Tier 1 consultant should understand the basic physiology of normal oropharyngeal and esophageal motor function, common disorders arising from dysfunction, utilization of esophageal function testing to diagnose these disorders, and initial management. The Tier 2 consultant should understand the indications, basic interpretation, utilization, limitations, and complications of diagnostic esophageal motor testing, and management of esophageal motor disorders. The Tier 3 consultant should have a detailed understanding of oropharyngeal and esophageal pathophysiology, provide performance and expert interpretation of esophageal function tests, and coordinate the management of motor disorders and their consequences.
Tier 1
• Understand the investigation of esophageal symptoms, particularly transit symptoms (dysphagia, esophageal regurgitation) that can lead to a diagnosis of esophageal motor disorders • Differentiate oropharyngeal from esophageal dysphagia and provide appropriate investigation and management, including recommendations for enteral feeding when appropriate • Comprehend diagnostic algorithms for oropharyngeal and esophageal dysphagia and develop knowledge to request appropriate diagnostic testing • Describe the pathophysiology, diagnosis, management, and complications of achalasia • Recognize situations where endoscopic intervention is indicated for the short-term and long-term management of esophageal motor disorders
Tier 2 • Understand in-depth physiology of oropharyngeal and esophageal contractility and peristalsis including neurohormonal regulation of deglutition and overlap with functional disorders • Describe the pathophysiology, diagnosis, management, and complications of major esophageal motor disorders, including EGJ outflow obstruction, aperistalsis, distal esophageal spasm, and jackhammer esophagus • Recognize conditions that may mimic or confound the diagnosis of esophageal motor disorders, including eosinophilic esophagitis, functional dysphagia, esophageal diverticula, organic obstructive syndromes, and gastro-esophageal reflux disease • Appreciate the indications, limitations, complications, and cost-effectiveness of diagnostic esophageal function studies, especially endoscopy, esophageal high-resolution manometry (HRM), and contrast radiography, for the diagnosis and guidance of management of esophageal motor disorders • Recall the pharmacology, efficacy, routes of administration, and appropriate use of medications for esophageal motor disorders • Understand the implications and management of minor motor disorders: ineffective esophageal motility, fragmented peristalsis • Understand the clinical sequelae of motor dysfunction including pharyngeo-esophageal and esophageal diverticula and their management • Recall the pharmacology, efficacy, routes of administration, and appropriate use of medications for esophageal motor disorders • Interpret esophageal manometry studies using the Chicago classification scheme • Provide appropriate use of invasive management options for oropharyngeal and esophageal motor disorders, including enteral feeding options in oropharyngeal motor disorders, endoscopic management including botulinum toxin injection (and with appropriate training, pneumatic dilation) in esophageal motor disorders • Appreciate the indications, limitations, and cost-effectiveness of diagnostic oropharyngeal function studies, especially high-resolution manometry (HRM), contrast radiography, and imaging options for the diagnosis, and guidance of management of oropharyngeal dysphagia • Recognize situations where surgical intervention is indicated for the short-term and long-term management of esophageal motor disorders
Tier 3
• Develop expertise to select appropriate invasive therapies for the management of complicated esophageal motor disorders (pneumatic dilation, POEM, surgery); perform pneumatic or hydraulic dilation for achalasia; performance of POEM will require advanced endoscopy training to acquire necessary skills, which can last up to a year • Provide expertise, performance, and interpretation of advanced investigative and therapeutic modalities including endo FLIP and postprandial HRM • Understand the evaluation and management of complications, and recurrent symptoms following initial management of motor disorders, especially achalasia • Distinguish overlapping functional esophageal symptoms from motor disorders and provide management recommendations • Provide opinion and expert management of oropharyngeal and esophageal motor disorders within the context of age and comorbid conditions • Recognize appropriate patients for complementary and adjunctive therapies for motor disorders, such as swallow exercises, cognitive and behavioral therapy, and hypnotherapy
Gastric motor disorders
Description Gastric motor function involves the complex modulation of neuromuscular activity through the central, autonomic, and enteric nervous systems, the interstitial cells of Cajal, and various neurotransmitters. Gastric motor disorders can present with nausea, vomiting, early satiety, postprandial distress, abdominal pain, bloating, and weight loss. The Tier 1 consultant should develop an understanding of the physiology of gastric neuromuscular function, diagnosis and management of common disorders arising from dysfunction, especially functional dyspepsia, gastroparesis, and vomiting syndromes. The Tier 2 consultant should have detailed understanding of gastric motor disorders and their presentation and should be able to interpret and utilize diagnostic tests (especially gastric scintigraphy) for the initial management of gastric motor dysfunction, including dietary, pharmacologic, and surgical interventions. The Tier 3 consultant should recognize the implications of gastric motor dysfunction and its consequences in the context of comorbid conditions and past management, provide expert interpretation of all aspects gastric motor testing, and lead multidisciplinary teams for the advanced non-invasive and invasive management of gastric motor disorders. gastric neurostimulation, pyloric botulinum toxin injection, venting gastrostomy, feeding jejunostomy, and gastric peroral endoscopic myotomy (GPOEM) Performance of GPOEM will require additional advanced endoscopy training for up to a year • Develop detailed understanding to provide expert consultation and management of complex gastric motor disorders within the context of comorbidities, past interventions including surgery, complications, and psychiatric disorders • Integrate multifaceted management of gastric motor disorders and coordinate a multispecialty team including dieticians, health psychologists, nutritionists, and surgeons • Utilize advanced and novel clinical and research modalities in evaluation and management of gastric motor function 6. Small bowel and colonic motor disease Description: Small bowel motor diseases, including pseudo-obstruction and intestinal failure, are infrequently encountered abnormalities, which may present with abdominal distension, ileus, vomiting, feeding intolerance, diarrhea, or abdominal pain. Colonic motor disorders are more common and can present with constipation, diarrhea, abdominal distention, nausea, and abdominal pain. The Tier 1 consultant should understand the clinical presentation and course of small bowel and colonic motor diseases, conditions that may mimic or confound their diagnosis and the indications, basic testing, as well as the initial management of these disorders including diet, medications, surgical, and supportive care. The Tier 2 consultant should understand advanced diagnostic procedures including laboratory tests, specific imaging modalities, assessment of motor function and knowledge regarding standard and non-standard treatment options. The Tier 3 consultant should develop expert knowledge in unraveling advanced motility disorders using complementary tests and have knowledge in the use of advanced treatment options of difficult cases including surgical options, intestinal transplantation, and advanced nutritional support.
TA B L E 2 (Continued)
• Develop a basic understanding of physiology of small intestine and colonic function including motor function, mucosal function, absorption of nutrients, and symptoms arising from dysfunction of the small bowel and colon • Review potential primary and secondary causes, clinical presentation and initial management of acute (ileus) and chronic small bowel, and colonic motor disorders • Recognize differential diagnosis of acute motor dysfunction of the small bowel and colon, including small bowel obstruction, strictures, volvulus, and ischemia • Recall the pharmacology, efficacy, routes of administration, and appropriate use of standard medications for small bowel and colonic motor disorders, including medications for management of chronic constipation and diarrhea • Recognize conditions that may mimic or confound the diagnosis of small intestinal, pancreas, and colonic motor disorders, including small intestinal bacterial overgrowth, functional gastrointestinal disorders, outlet constipation, diverticular disease, and inflammatory disorders (inflammatory bowel disease, celiac disease, radiation enteritis, infectious colitis, microscopic colitis, etc.) • Recognize the role for breath hydrogen testing for carbohydrate intolerance (lactose, fructose, and sucrose intolerance), and small bowel bacterial overgrowth in patients with abdominal symptoms • Understand nutritional support options for patients with small bowel motor disorders (especially pseudo-obstruction) • Appreciate the indications, limitations, complications, and cost-effectiveness of studies assessing gut transit, particularly the use of radio-opaque markers • Recognize situations where endoscopic and/or surgical intervention is indicated for the short-and long-term management of small bowel and colonic motor disorders Tier 2
• Understand detailed pathophysiology of acute and chronic motor disorders of the small bowel and colon, including their differential diagnosis • Develop knowledge on the indications for endoscopic and surgical options for the management of small bowel and colonic motor disorders • Provide interpretation of breath tests for carbohydrate intolerance and small bowel bacterial overgrowth in difficult and atypical cases • Recognize the role of systemic disease, side effects of medications and consequences of bowel surgery as a mechanism for small bowel and colonic motor dysfunction and bowel transit symptoms • Recognize implications of pancreatic endocrine insufficiency (diabetes with gastroparesis/autonomic dysfunction) and secondary motility disorders (eg, systemic sclerosis and spinal cord injuries) on patient presentation and investigation • Recognize the clinical value of imaging and scintigraphic modalities in the diagnosis and management of small bowel and colonic motility disorders • Develop knowledge in the use of advanced pharmacological and non-pharmacological treatments of motility disorders and including the use off-label drugs Tier 3
• Understand the function of gut peptides and their role in gut motor and secretory function • Develop the understanding and experience in advanced assessment of small bowel and colonic motor function, including wireless motility capsule, antro-duodeno-jejunal motility testing, colonic motility testing, scintigraphy, and novel techniques • Develop expertise in advanced management of nutrition needs, including enteral and parenteral nutrition and its complications, utilization of surgical ostomy in management of small bowel and colonic motor disorders • Recognize experimental treatment of common and rare small bowel and colonic motor disorders, including prokinetics, neuromodulators, symptomatic agents, and atypical agents • Recognize patients who might benefit from small bowel transplantation, ostomy, and colectomy for advanced and complex small bowel and colonic motor disorders 7. Pelvic floor disorders Description Pelvic floor disorders encompass a variety of disorders and can present with symptoms related to constipation (straining, splinting, and incomplete evacuation), fecal incontinence (unintentional passage of flatus, and stool seepage), and pain (abdominal distention and pelvic pain). Pelvic floor disorders have a significant impact on quality of life and can lead a debilitating course. Pelvic floor disorders are of multifactorial origin and cover a wide spectrum of recognized mechanisms and incompletely understood pathophysiology. The Tier 1 consultant should understand the basic anatomy and physiology of the pelvic floor, diagnostic criteria for common pelvic floor disorders (functional defecatory disorders and fecal incontinence) including overlap of structural and functional disease, indications for diagnostic studies and both pharmaceutical and non-pharmaceutical options (biofeedback). Tier 2 consultants should become familiar with performing and interpreting anorectal diagnostics, learn the role, limitations, and caveats of anorectal surgical procedures, and understand complex medical pelvic floor disorders (pelvic pain disorders and neuromuscular disease). Tier 3 consultants should be familiar with state of the art manometric, radiologic, ultrasound and barostat-based anorectal diagnostics, develop expertise in collaboration with associated specialties to integrate management of patients with difficult, therapy-refractory, and structurally disrupted pelvic floor disease secondary to trauma, birth defects, neuromuscular disorders, and surgical complications. Mucosal disorders are important in that they may mimic or coexist with functional and motor GI disorders. Foregut mucosal disorders include GERD, eosinophilic esophagitis, and peptic ulcer disease manifesting with heartburn, regurgitation, dysphagia, chest and epigastric, bloating, early satiety, nausea, weight loss, or their complications such as upper gastrointestinal bleeding and perforation. Small bowel and colonic mucosal disorders include celiac disease, inflammatory bowel disease, gastroenteritis and infectious colitis, radiation enteritis, and other less common inflammatory conditions, manifesting as alteration of bowel function, bloating, and abdominal pain. The Tier 1 consultant should understand the evaluation of gut symptoms, particularly the indications, basic interpretation, utilization, limitations, and complications of testing in the context of mucosal disorders and the basic management gut mucosal disorders. The Tier 2 consultant should recognize the overlap of mucosal disorders with functional disorders and symptoms, and understand appropriate evaluation and management of mucosal disorders. The Tier 3 consultant should have in-depth understanding of the presentation and diagnosis of mucosal disorders of the gut and recognize the interface between organic and functional disorders in managing symptoms from overlapping mucosal disorders.
(
Tier 1
• Appreciate normal gut morphology and function, pathophysiology and mechanisms underlying mucosal protective mechanisms, and pathophysiology of gut mucosal disorders that share symptoms with functional bowel disorders.
• Recognize the indications, limitations, complications, and cost-effectiveness of diagnostic and therapeutic endoscopy and diagnostic testing for H. pylori • Understand the diagnosis and basic management approaches for eosinophilic esophagitis • Understand the diagnosis and basic management of infectious (candida, HSV, and CMV) and inflammatory (radiation, caustic ingestions, and pill-induced) esophagitis • Understand the etiology, pathogenesis, diagnosis, complications, and management of peptic ulcer disease (including indications for surgery) and recognize conditions that mimic or confound the diagnosis • Recognize inflammatory and infectious disorders of the small bowel and colon (eg, inflammatory bowel disease, celiac disease, radiation enteritis, infectious colitis, and microscopic colitis) 
TA B L E 2 (Continued)
10. Consequences of systemic disease, medications, and radiation therapy Description Consequences of systemic disease and medications can pose significant morbidity and the clinical presentation can be varied. The use of medications can affect gastrointestinal motility resulting in new onset or worsening symptoms, dysmotility, and dysfunction. The Tier 1 consultant should understand the potential implications of systemic diseases and medications on GI motor function and functional bowel disease. The Tier 2 consultant should also understand the indications, utilization, limitations, and implications of diagnostic testing, and the initial management of systemic disease and medications that impact GI motility. The Tier 3 consultant should develop in-depth understanding of pathophysiology of systemic disease affecting bowel motor function and provide expert consultation regarding risk vs benefit of medications with potential gastrointestinal motor consequences Tier 1 • Understand the most common systemic diseases and their impact on GI motor function and functional bowel disease • Be aware that connective tissue disorders such as scleroderma, paraneoplastic disorders, neuromuscular disorders, and endocrine disorders such as diabetes affect GI motility • Recall the pharmacology, mechanism of action, and the effect of current and past use of medications that impact GI motility, such as opioids, chemotherapy, and anticholinergic agents.
• Understand the timeline, presentation, diagnosis, management, and complications of radiation injury to the GI tract, such as dysmotility, stricture, ulceration, bleeding, fibrosis, and fistula • Recognize situations where surgical and nutritional intervention is indicated for the management of systemic diseases that affect the GI tract.
• Recognize the effects of opioids, cannabinoids, and recreational drug use on gut symptoms and motor function Tier 2
• Describe the pathophysiology, diagnosis, management, and complications of systemic diseases such as connective tissue disorders, paraneoplastic dysmotility, autoimmune disorders, hypothyroidism, amyloidosis, infections, connective tissues diseases, mitochondrial diseases, muscular dystrophy, endocrine and metabolic disorders, autonomic neuropathies, central nervous system diseases including Parkinson's diseases and intracranial masses, sepsis, malnutrition, and renal insufficiency • Understand in depth the effect of current or past treatments on GI motor function and functional bowel disease including chemotherapy, radiation, opioids, antiparkinsonian medications and isoniazid, tricyclic antidepressants, phenothiazines, and proton pump inhibitors • Be familiar with the indications, limitations, complications, and cost-effectiveness of diagnostic studies, such as manometry, GI transit studies, endoscopy, and imaging studies for the diagnosis and guidance of the management of systemic diseases that affect GI motility • Understand the management of consequences of effects of opioids, cannabinoids, and recreational drug use on bowel function Tier 3
• Interpret physiologic tests and provide context in patients with systemic disease • Provide opinion regarding medication effects on gut mucosal and motor function • Make recommendations for surgical and nutritional intervention in systemic diseases affecting the GI tract • Understand the role of discontinuation of redundant or unnecessary medications that affect gut function • Provide expert opinion and management of narcotic bowel syndrome, cannabinoid hyperemesis syndrome, consequences of opioid usage, and drug-seeking behavior 11. Pediatric transition to adult neurogastroenterology Description Pediatric neurogastroenterology has higher proportions of congenital motor and metabolic disorders, perinatal neurological or gastrointestinal injuries compared to adults, the need to obtain history from parents to caregivers, and significant influence of family and peers on the illness experience. Some congenital-and childhood-onset disorders and aspects of pediatric care are relevant to the adult gastroenterologist as children transition to adulthood and seek medical evaluation and treatment. The Tier 1 consultant should understand basic aspects of pediatric gastroenterology and facilitate the transition of care of adolescents with chronic diseases/disorders to the adult gastroenterologist, integrating the entire life cycle. The Tier 2 consultant should have a deeper understanding of pediatric neurogastroenterology and will need to develop skills and expertise to manage routine neurogastroenterologic disorders in adolescents and young adults transitioning to adult care. The Tier 3 consultant should have expertise in neurogastroenterologic disorders afflicting adolescents and young adults and should seamlessly transition care of even complicated pediatric neurogastroenterology and motility disorders that continue into adulthood.
Tier 1 • Understand diseases that start in childhood and continue into adulthood (eg, Hirschsprung, anorectal malformations, tracheo-esophageal fistula/esophageal atresia, functional constipation, irritable bowel syndrome, functional dyspepsia) • Understand risk factors for FGIDs including early life events and the role of family, school, and peers in the onset and course of pediatric FGIDs • Understand that developmental stage, physiologic changes in adolescence, and psychosocial dynamics are integral to care of pediatric patients • Understand that effective transition is a process involving the patient, family, and pediatric and adult medical providers • Recognize that for the patient, seeing an adult provider is a novel experience and style of practice and expectations may differ from pediatric care TA B L E 2 (Continued) (Continues) eosinophilic esophagitis, Helicobacter pylori gastritis, and other gastric mucosal pathology, celiac disease, and microscopic colitis needed to be within the radar of NGM expertise. It was evident that there were differences in expectations of NGM training between countries, and that some countries had broader expectations for knowledge and expertise in conditions mimicking NGM disorders. For instance, pancreatic pain and understanding of pancreatic exocrine insufficiency were considered part of NGM knowledge in some European countries, contrary to US training where pancreatic disorders are typically managed by pancreaticobiliary experts. In recognition of these differences, the curriculum content is broad and inclusive, so that it can be applicable to as many settings as possible. The expectation is that each country and NGM society utilizing the curriculum can adapt content to their specific requirements.
The task forces discussed pediatric disorders and training at length with pediatric experts engaged in the curriculum project. The overall • Understand unique aspects of diagnostic criteria for children with FGID • Transition complex pediatric and adolescent patients with chronic mucosal, motor, and functional disorders efficiently into adult neurogastroenterology practice • Understand sequela of the past medical and surgical treatments for chronic motor and functional diseases in children and adolescents • Understand historical perspective regarding obsolete surgical and invasive procedures that patients might have undergone in the past • Recognize that the young adult may seek independence from family participation in their care, address concerns and allay anxiety in both patients and family members • Provide guidance, expertise, and insight into management of disorders of neurogastroenterology and motility in adolescents and young adults TA B L E 2 (Continued) conclusion was that pediatric and adult practices differ widely in their disease content. Similar to core specialty training differences, NGM training requirements are different enough between pediatric and adult practices that a single curriculum would not do justice to either adult or pediatric NGM training. 6, 13 Instead, the curriculum needs to be replicated within the pediatric spectrum in order to highlight unique elements of pediatric training that are different from expectations from adult NGM training, since pediatric NGM training is only addressed in a very limited fashion in the pediatric GI curriculum. 13 One area of importance to adult NGM training consists of transition of pediatric patients into adult practices. Adult NGM training currently lacks not only training components that focus on transition elements that incorporate unique knowledge components but also unique skills, attitudes, and values that are needed to address the transition (Table 3) . This transition to adult care needs specific training, understanding of common pediatric diagnoses, attention to the patient's variable knowledge and skills to manage disease independently, and recognition of the role of parents and caregivers in the care of younger patients.
| S K ILL S , AT TITUDE S , AND VALUE S
NGM training involves not just clinical knowledge but also training in procedural skills and adoption of compassionate attitudes and values in evaluation and management of complex patients, many with psychological comorbidities and poor quality of health. The expected skills, attitudes, and values expected of each tier of NGM training are described in Table 3 .
Special listening skills, compassion, and empathy are essential qualities of all physicians, but these qualities are especially The task forces felt that trainees acquire these skills in a tiered fashion, with a higher degree of investment, understanding and acquisition of such skills and attitudes with deeper involvement in NGM, which could include spending time at an NGM center of excellence. In particular, transition of pediatric NGM patients into adult practices requires special skills that need special attention and experience during each tier of training (Table 3) .
Since NGM expertise involves the interpretation of gut function and motility studies, the task forces carefully assessed these components of training. There was unanimous agreement that specific training and expertise were needed for interpretation of gut function and motility studies, and that such expertise was outside the realm of the Tier 1 trainee. Instead, the Tier 1 trainee needed to understand when to order these studies, 12 Therefore, it is anticipated that the curriculum can be adapted to these special circumstances to ensure quality of the NGM services provided. Furthermore, the 1-month CTP is only the point of initiation of advanced training and may not be adequate for interpretation of all gut function and motility studies; limited data available suggest that skills in interpretation of breath tests and anorectal manometry are the simplest to acquire, but interpretation of other function tests is more complex. 3 The Tier 3 trainee is expected to gain skills in advanced interpretation of gut function and motility studies relevant to their chosen NGM domain(s) of expertise.
The advanced NGM trainee is expected to be involved in investigation and scholarly activity, and in writing, presentation, and publication. These are essential tenets of a successful NGM career and thought leader status. Consequently, training in NGM requires involvement of mentors at all tiers of training, who can guide the trainee in identifying and achieving their career goals.
| E VALUATI ON OF OUTCOME
The success of an NGM training program can be assessed by the ability of the trainee to function as a specialist or consultant within NGM, providing appropriate care and consultative services for NGM patients, interpreting NGM function studies, directing an NGM testing facility, performing research within NGM, mentoring of future trainees, and becoming a thought leader in the field. 9, 12 While many of these metrics do not lend themselves to easy measurement tools, clinical knowledge and interpretation skills can be evaluated, and career trajectories can be followed over time.
The ANMS has an ongoing CTP for Tier 2 training in NGM, in existence for over a decade. 3, 12 The CTP program currently administers a 60 multiple choice question test before and after the 1-month observership, and significant increments in test scores are reported between pre-and post-CTP scores. 3, 12 However, trainees and training institutions both indicate that the 1-month CTP apprenticeship is not long enough for a robust training experience, 12 and that the outcome of the experience is highly dependent on the enthusiasm and enterprise of the trainee and the resources at the mentoring institution. Nevertheless, the limited outcome data available suggest that at least a third of CTP trainees desire further involvement in the field of NGM, and many move on to successful careers in NGM. Following endoscopic training paradigms, certain elements of NGM training involving interpretation of motility studies and function testing lend themselves to counting numbers of studies performed and reaching an arbitrary number. 12 However, the study of learning curves for interpretation of motility studies, for instance, suggests that simple numeric thresholds do not establish competence in identification of all motor disorders, 17, 18 even though new analysis paradigms and software tools have made interpretation more accurate and less cumbersome. 19, 20 Instead, there are variations in learning patterns between trainees that cannot be overcome by case volume alone. 18 An approach that starts with the definition of quality metrics of appropriate test interpretation, 21 and utilizes training that focuses on observable and measurable metrics, has a greater chance of providing competency in test interpretation. 
| CON CLUS I ON AND FUTURE DIREC TION
Gastroenterology training may be the opportune time when trainees shape their career paths, and availability of appropriate NGM resources and opportunities during this period will ensure broader participation in the NGM field. The NGM curriculum has potential to outline the structure of Tier 1 NGM training during standard gastroenterology training, ensuring that interested trainees are well prepared for Tier 2 experiences. Regular updates of the NGM curriculum will be necessary as scientific knowledge and function testing evolve, and training paradigms change; NGM societies will need to invest in the process of revision and renewal of the concepts described in this document.
Programs such as the CTP have been demonstrated to be successful at the Tier 2 level, despite limitations in duration of rotations.
The development of training modules specifically targeted at Tier 2 test interpretation skills, with embedded competency assessment and credentialing components, have potential to enhance the value
